东莨菪碱市场：按剂型、通路、地区

预计2024年全球东莨菪碱市场规模为4.851亿美元，预计2031年将达到7.392亿美元，2024年至2031年复合年增长率为6.2%。

图 1. 2024 年东莨菪碱市场占有率(%)，依地区划分

东莨菪碱是一种常用于控制晕动病和噁心的药物化合物。由于娱乐性药物的使用增加和许多最终用途行业的应用增加等因素，全球东莨菪碱市场在过去几年中稳步增长。东莨菪碱主要从茄科植物中提取，其中曼陀罗或曼陀罗是主要的商业性来源。它作为脑干和中枢神经系统其他部分的毒蕈碱乙酰胆碱受体的竞争性拮抗剂，阻断来自前庭系统的影响平衡和运动感知的讯号。它有多种剂型，包括锭剂、贴片和注射剂，可有效控制晕动病、术后噁心和呕吐以及与癌症化疗相关的噁心等症状。

市场动态：

海上和空中旅行的增加、止吐药消费量的增加以及东莨菪碱贴剂用于术后护理的临床使用的增加可能会推动全球东莨菪碱市场的成长。然而，与过量服用相关的副作用以及从植物来源中提取生物碱的规定可能会阻碍市场成长。继续研究和开发新的盖伦製剂、专注于联合治疗以及评估新的治疗应用可能会为市场相关人员提供机会。原物料价格的波动也会影响市场参与企业的供应和定价策略。

本研究的主要特点

• 本报告对全球东莨菪碱市场进行了详细分析，并提出了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
• 它揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球东莨菪碱市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球东莨菪碱市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于全球东莨菪碱市场分析的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行概述
• 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球东莨菪碱市场－冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球东莨菪碱市场，按剂型，2019-2031，（百万美元）

• 介绍
• 锭剂
• 糖浆
• 注射
• 修补
• 其他的

第六章 全球东莨菪碱市场，依通路划分，2019-2031 年（百万美元）

• 介绍
• 医院药房
• 零售药房
• 网路药房

第七章全球东莨菪碱市场，按地区，2019-2031，（百万美元）

• 介绍
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第八章 竞争格局

• 公司简介
  • Alchem International
  • Integra LifeSciences Holding Corporation
  • Alkaloids Corporation
  • Boehringer Ingelheim
  • Caleb Pharmaceuticals, Inc.
  • Centroflora Group
  • Fine Chemicals Corporation
  • GlaxoSmithKline plc
  • Henan Fusen Pharmaceutical Co., Ltd.
  • Laboratorio RAAM de Sahuayo
  • Mylan NV（part of Viatris）
  • Novartis AG
  • Pfizer Inc.
  • Pharmaceutical Associates, Inc.
  • Phytex Australia
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Global Alkaloids

第九章 分析师建议

• 升起和降落
• 综合机会图

第10章 参考文献与调查方法

• 参考
• 调查方法

Global scopolamine market is estimated to be valued at USD 485.1 Mn in 2024 and is expected to reach USD 739.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

Figure 1. Scopolamine Market Share (%), By Region, 2024

Scopolamine is a pharmaceutical compound that is commonly used to curb motion sickness and nausea. Global scopolamine market has witnessed steady growth over the past few due to factors such as increasing recreational drug usage and rising application across numerous end-use industries. Scopolamine is predominantly extracted from plants belonging to the Solanaceae family of which Datura stramonium or Jimson weed is the major commercial source. It acts as a competitive antagonist of muscarinic acetylcholine receptors in the brainstem and other parts of the central nervous system to block signals from the vestibular system affecting balance and motion perception. The drug is available in various dosage forms including tablets, patches, and injections to effectively manage symptoms of motion sickness, post-operative nausea & vomiting, and nausea associated with cancer chemotherapy.

Market Dynamics:

Rising sea and air travel, increasing consumption of antiemetic drugs, and growing clinical use of scopolamine patches for postoperative care can drive the global scopolamine market growth. However, adverse effects associated with overdosage and restrictions on plant-derived alkaloids extraction can hamper the market growth. Ongoing R&D to develop new galenic formulations, focus on combination therapies, and evaluation of additional therapeutic applications can offer opportunities for market players. Fluctuating prices of raw materials also impact the supply and pricing strategies adopted by different market participants.

Key Features of the Study:

• This report provides in-depth analysis of the global scopolamine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global scopolamine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Pfizer, Baxter, Caleb Pharmaceuticals, Alkaloids of Australia.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global scopolamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scopolamine market.

Detailed Segmentation-

• By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Alchem International
  • Integra LifeSciences Holding Corporation
  • Alkaloids Corporation
  • Boehringer Ingelheim
  • Caleb Pharmaceuticals, Inc.
  • Centroflora Group
  • Fine Chemicals Corporation
  • GlaxoSmithKline plc
  • Henan Fusen Pharmaceutical Co., Ltd.
  • Laboratorio RAAM de Sahuayo
  • Mylan N.V. (part of Viatris)
  • Novartis AG
  • Pfizer Inc.
  • Pharmaceutical Associates, Inc.
  • Phytex Australia
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Global Alkaloids

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Dosage Form
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Scopolamine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Scopolamine Market, By Dosage Form, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Tablet
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Syrup
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Patch
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Scopolamine Market, By Distribution Channel, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Scopolamine Market, By Region, 2019 - 2031, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Alchem International
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Integra LifeSciences Holding Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alkaloids Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Caleb Pharmaceuticals, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Centroflora Group
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fine Chemicals Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GlaxoSmithKline plc
  • Henan Fusen Pharmaceutical Co., Ltd.
  • Laboratorio RAAM de Sahuayo
  • Mylan N.V. (part of Viatris)
  • Novartis AG
  • Pfizer Inc.
  • Pharmaceutical Associates, Inc.
  • Phytex Australia
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Global Alkaloids

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact